by Dr Karthik Masagounder, Head Aqua and Swine
Research, Evonik Nutrition and Care GmbH, Germany and Dr D Allen Davis,
Professor, Auburn University, USA
An in-vitro study based on the enzymes extracted from shrimp hepatopancreas
showed that shrimp are able to completely cleave the four available isomers of
DL-methionyl-DL-methionine (AQUAVI® Met-Met) but at different rates. This
allows delayed liberation and absorption of D- and L- Methionine (Met) in the
digestive tract. However, no in-vivo data were published showing changes in the
postprandial profile of Met in the hemolymph – a fluid analogous to the blood
in vertebrates – of shrimp fed different Met sources.
We therefore instigated a study to investigate and compare postprandial Met
levels in relation to other amino acids in the hemolymph of whiteleg shrimp fed
diets supplemented with AQUAVI® Met-Met or DL-Met. The effects of different
sources on the Met levels of shrimp hemolymph were evaluated under two feeding
frequencies (once per day and three times per day) to understand if the feeding
frequency would influence the dietary effects on the hemolymph Met levels.
Met is typically the first limiting amino acid in the practical shrimp feed and
therefore its supplementation is essential. Previous studies showed that
AQUAVI® Met-Met is a more efficient Met source (≥ 200%) for shrimp compared with DL-Met (Xie et
al. 2017; Niu et al. 2018). Better bioavailability of AQUAVI® Met-Met versus
DL-Met is attributed mainly to (i) its less water solubility and leaching and
(ii) slow and long release of Met from different sterioisomers (DL-Met-Met,
LD-Met-Met, LL-Met-Met, DD-Met-Met).
Read more, HERE.
The Aquaculturists
No comments:
Post a Comment